Neurofunctional alterations of cognitive down-regulation of craving in quitting motivated smokers.


Journal

Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors
ISSN: 1939-1501
Titre abrégé: Psychol Addict Behav
Pays: United States
ID NLM: 8802734

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 18 2 2022
medline: 20 12 2022
entrez: 17 2 2022
Statut: ppublish

Résumé

Cognitive down-regulation of craving involves a neural network within the prefrontal cortex. Tobacco use disorder (TUD) and trait impulsivity have been associated with prefrontal cortex impairments and down-regulation deficits. However, general deficits in down-regulation of craving (regarding non-drug-related cues) compared to never-smokers (NS), differential alterations between drug-related and non-drug-related cues, as well as its links to subject characteristics (smoking severity, trait impulsivity) have so far sparsely been investigated in TUD. In this study, 78 subjects (37 TUD & 42 NS) underwent functional magnetic resonance imaging while performing a down-regulation of craving task. Two reward cue-types were presented (drug cues and alternative rewards). Subjects applied down-regulation of craving during a LATER condition and up-regulated their craving during a NOW condition. Subjective craving ratings were assessed after each trial. To evaluate down-regulation of craving, we investigated the LATER versus NOW condition. TUD subjects showed no differences in down-regulation on a behavioral level, neither compared to NS nor between the two reward cue-types. On a neurofunctional level, we found a stronger BOLD response in the middle temporal gyrus in TUD subjects compared to NS in the alternative reward condition. No differences between the two reward cue-types were found within TUD subjects. During down-regulation across both reward cue-types, we identified significant negative associations between activation of control areas and smoking severity. Results neither indicate evidence for the expected general alterations in down-regulation of craving in TUD, compared to NS, nor specific alterations between drug-related and alternative reward cues on a neurofunctional level. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Identifiants

pubmed: 35175067
pii: 2022-33159-001
doi: 10.1037/adb0000820
doi:

Banques de données

ClinicalTrials.gov
['NCT04251936']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1012-1022

Subventions

Organisme : German Research Foundation (DFG)

Auteurs

Stefanie L Kunas (SL)

Department of Psychiatry and Neuroscience.

Heiner Stuke (H)

Department of Psychiatry and Neuroscience.

Irene S Plank (IS)

Department of Psychiatry and Neuroscience.

Ebba M Laing (EM)

Department of Psychiatry and Neuroscience.

Felix Bermpohl (F)

Department of Psychiatry and Neuroscience.

Andreas Ströhle (A)

Department of Psychiatry and Neuroscience.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH